WallStreetZenWallStreetZen

NYSE: ZTS
Zoetis Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ZTS past earnings growth

How has ZTS's earnings growth performed historically?
Company
12.64%
Industry
13.52%
Market
71.87%
ZTS's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ZTS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ZTS's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ZTS past revenue growth

How has ZTS's revenue growth performed historically?
Company
5.74%
Industry
10.18%
Market
17.2%
ZTS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ZTS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ZTS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ZTS earnings and revenue history

Current Revenue
$8.5B
Current Earnings
$2.3B
Current Profit Margin
27.4%
ZTS's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ZTS Return on Equity

Current Company
48.8%
Current Industry
15.4%
Current Market
188%
ZTS's Return on Equity (48.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ZTS announces earnings.

ZTS Return on Assets

Current Company
16.8%
Current Industry
3.4%
ZTS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ZTS Return on Capital Employed

Current Company
25.64%
Current Industry
5.1%
ZTS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ZTS vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ZTS$8.54B$3.67B$2.34B+7.96%+11.41%
TAK$28.38B$7.34B$1.21B+12.67%-8.81%
HLN$14.31B$2.70B$1.33B+6.41%-88.62%
TEVA$15.85B$1.64B-$559.00M-2.81%N/A
NBIX$1.89B$358.00M$249.70M+33.13%+61.92%
View Top Pharmaceutical Stocks

ZTS earnings dates

Next earnings date
May 2, 2024

Zoetis Earnings & Revenue FAQ

What were ZTS's earnings last quarter?

On Invalid Date, Zoetis (NYSE: ZTS) reported Q4 2023 earnings per share (EPS) of $1.14, up 15.15% year over year. Total Zoetis earnings for the quarter were $525.00 million. In the same quarter last year, Zoetis's earnings per share (EPS) was $0.99.

If you're new to stock investing, here's how to buy Zoetis stock.

What was ZTS's earnings growth in the past year?

As of Q2 2024, Zoetis's earnings has grown 12.64% year over year. This is 0.88 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 13.52%. Zoetis's earnings in the past year totalled $2.34 billion.

What is ZTS's earnings date?

Zoetis's earnings date is Invalid Date. Add ZTS to your watchlist to be reminded of ZTS's next earnings announcement.

What was ZTS's revenue last quarter?

On Invalid Date, Zoetis (NYSE: ZTS) reported Q4 2023 revenue of $2.21 billion up 8.48% year over year. In the same quarter last year, Zoetis's revenue was $2.04 billion.

What was ZTS's revenue growth in the past year?

As of Q2 2024, Zoetis's revenue has grown 5.74% year over year. This is 4.44 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.18%. Zoetis's revenue in the past year totalled $8.54 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.